EDGAR Filing Documents for 0000921895-20-001581

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000921895-20-001581

Filing Date

2020-05-22

Accepted

2020-05-22 17:22:01

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	THE SCHEDULE 13G	sc13g07422sut_05222020.htm	SC 13G	277733
2	JOINT FILING AGREEMENT	ex991to13g07422sut_05222020.htm	EX-99.1	10443
	Complete submission text file	0000921895-20-001581.txt		289830

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104

Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080

Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90656 | Film No.: 20907131
SIC: 2836 Biological Products, (No Diagnostic Substances)